Catalent, Inc - Financial News

2020 2019 2018 2017 2016 2015 2014 2013

05/28/2020

Catalent, Inc. to Present at June 2020 Virtual Investor Conferences

05/08/2020

Catalent, Inc. to Present at May 2020 Virtual Investor Conferences

05/05/2020

Catalent, Inc. Reports Third Quarter Fiscal 2020 Results

05/04/2020

Arcturus Therapeutics and Catalent Announce Partnership to Manufacture mRNA-Based COVID-19 Vaccine

04/30/2020

Catalent Announces Next Generation of Cell & Gene Therapy Leadership

04/29/2020

Catalent Signs Agreement with Johnson & Johnson to be U.S. Manufacturing Partner for Lead COVID-19 Vaccine Candidate

04/15/2020

Catalent, Inc. Announces Third Quarter Fiscal Year 2020 Earnings Conference Webcast

04/13/2020

Catalent Publishes Fiscal 2019 Corporate Responsibility Report

03/09/2020

Catalent, Inc. to Present at the Barclays Global Healthcare Conference

02/20/2020

Catalent Announces Upsizing and Pricing of Private Offering of Senior Unsecured Notes Due 2028

02/19/2020

Catalent Announces Launch of Private Offering of €450 Million of Senior Unsecured Notes Due 2028

02/18/2020

Catalent, Inc. to Present at the 9th Annual SVB Leerink Global Healthcare Conference

02/10/2020

Catalent Completes Acquisition of MaSTherCell

02/03/2020

Catalent, Inc. Announces Pricing of Public Offering of Common Stock

02/03/2020

Catalent, Inc. Announces Public Offering of Common Stock

02/03/2020

Catalent, Inc. Reports Second Quarter Fiscal 2020 Results

02/03/2020

Catalent To Acquire Leading Cell Therapy Company MaSTherCell Global for $315 Million, Creating an Industry-Leading Cell & Gene Therapy Platform

01/16/2020

Catalent Further Strengthens Biologics Business with Key Senior Appointments

01/15/2020

Catalent, Inc. Announces Second Quarter Fiscal Year 2020 Earnings Conference Webcast

01/07/2020

Catalent, Inc. to Present at the 38th Annual J.P. Morgan Health Care Conference